agilon health (NYSE:AGL) Shares Down 5.2% – Time to Sell?

agilon health, inc. (NYSE:AGL) dropped 5.2% during mid-day trading on Friday . The company traded as low as $3.44 and last traded at $3.41. Approximately 707,214 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 5,263,885 shares. The stock had previously closed at $3.59.

Analyst Upgrades and Downgrades

Several research firms have commented on AGL. Stifel Nicolaus lowered their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and raised their price objective for the company from $1.75 to $2.25 in a report on Friday, January 10th. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Needham & Company LLC started coverage on shares of agilon health in a research note on Friday, January 10th. They issued a “hold” rating on the stock. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $4.03.

agilon health Stock Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a fifty day simple moving average of $2.41 and a two-hundred day simple moving average of $3.49. The stock has a market cap of $1.38 billion, a PE ratio of -3.59 and a beta of 0.53.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the business earned ($0.06) earnings per share. Equities analysts anticipate that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The stock was bought at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock valued at $198,100 over the last quarter. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Large investors have recently added to or reduced their stakes in the company. Bank of Montreal Can acquired a new position in agilon health in the second quarter worth approximately $404,000. AQR Capital Management LLC lifted its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the period. The Manufacturers Life Insurance Company grew its stake in agilon health by 30.1% during the second quarter. The Manufacturers Life Insurance Company now owns 279,143 shares of the company’s stock worth $1,826,000 after buying an additional 64,528 shares during the last quarter. Mackenzie Financial Corp bought a new position in agilon health in the 2nd quarter valued at $145,000. Finally, Algert Global LLC grew its stake in shares of agilon health by 398.6% during the second quarter. Algert Global LLC now owns 102,407 shares of the company’s stock valued at $670,000 after purchasing an additional 81,867 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.